The Pennant Group (PNTG) Reports Q4 Earnings: What Key Metrics Have to Say

Core Insights - The Pennant Group, Inc. reported a revenue of $289.32 million for the quarter ended December 2025, marking a year-over-year increase of 53.2% and an EPS of $0.34 compared to $0.24 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $273.04 million by 5.97%, while the EPS also surpassed the consensus estimate of $0.31 by 8.52% [1] Revenue Breakdown - Home health services revenue reached $116.43 million, exceeding the estimated $112.9 million, reflecting a year-over-year increase of 74.4% [4] - Hospice services generated $97.06 million, surpassing the estimated $92.42 million, with a year-over-year growth of 53.1% [4] - Senior living services reported revenue of $56.05 million, slightly below the estimated $57.06 million, but still showing a year-over-year increase of 19.6% [4] - Total revenue from home health and hospice services was $233.27 million, exceeding the average estimate of $220.6 million, representing a year-over-year change of 64.3% [4] - Home care and other services generated $19.78 million, surpassing the estimated $15.28 million, with a year-over-year increase of 66.7% [4] Stock Performance - The shares of The Pennant Group have returned +20.4% over the past month, significantly outperforming the Zacks S&P 500 composite, which changed by +0.6% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]